Hebon Bio: Announcement of Abnormal Fluctuations in Stock Trading

NightAirdropper · 2026-03-01T21:59:00+00:00

Hebang Biotech announced that the stock price increased by more than 20% within three trading days, meeting the criteria for abnormal fluctuations. The company's self-inspection found no significant events affecting the price movement, nor any undisclosed important information.

NightAirdropper

2026-03-01 21:59:00

Abstract generation in progress

Securities Daily Online News: On February 26, HeBang Bio announced that the company’s stock closing prices on February 24, 25, and 26, 2026, experienced a cumulative deviation of more than 20% over three consecutive trading days. According to the relevant regulations of the Shanghai Stock Exchange Trading Rules, this constitutes an abnormal fluctuation in stock trading. After self-inspection and written inquiries with the company’s controlling shareholder and actual controller, as of the date of this announcement, aside from information already disclosed on designated information disclosure media, there are no major matters affecting the company’s stock price abnormal fluctuations; there are no other major issues involving the company that should be disclosed but have not been disclosed, including but not limited to major asset restructuring, share issuance, significant transactions, business restructuring, share repurchase, equity incentives, bankruptcy reorganization, major business cooperation, or introduction of strategic investors.

(Edited by Cong Kexin)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.